揭开骨质疏松症:关键基因和潜在的治疗方法
Huichao Fu1, Yunjiao Wu2, Hongfei Lv1
1Department of Orthopedic Surgery, Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang, China.
Journal of cellular and molecular medicine
|August 6, 2025
概括
这项研究确定了FMO4,PSMA4和VEGFA作为与骨质疏松风险相关的关键基因. 这些发现为代谢性骨病治疗提供了潜在的新治疗点.
科学领域:
- 遗传学和分子生物学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨质疏松症是一种普遍的代谢性骨病,导致骨质减少和骨折风险增加,特别是在老年妇女中.
- 现有的骨质疏松症治疗有局限性和副作用,需要确定新的治疗点.
研究的目的:
- 使用孟德尔随机化 (MR) 和GWAS数据识别与骨质疏松症相关的可药物基因.
- 探索已识别的骨质疏松症相关基因的分子机制,免疫相关性和信号通路.
- 根据已识别的基因标,建议针对骨质疏松症的潜在治疗化合物.
主要方法:
- 孟德尔随机化 (MR) 分析来自FinnGen联盟的GWAS数据.
- 转录基因分析,单细胞RNA测序 (scRNA-seq) 和免疫透分析.
- 基因组丰富分析 (GSEA) 和基因组变异分析 (GSVA) 用于研究信号通路.
主要成果:
- 三种基因 - - FMO4,PSMA4和VEGFA - - 与骨质疏松症风险显著相关.
- FMO4表现出一种保护性关联,在血管和免疫细胞中丰富.
- 在巨细胞和T细胞中,PSMA4被上调,可能会通过免疫相关的蛋白质降解影响骨重塑.
- 维格法表达与骨质疏松症风险正相关,可能是通过ER-β介导的信号促进骨质细胞亡.
- 已识别的基因涉及信号传递,Wnt/β-catenin,PI3K/Akt和刺信号传递途径.
- 免疫分析揭示了与树突细胞和巨细胞的强烈关联.
- 确定了52个VEGFA候选化合物和8个PSMA4候选化合物.
结论:
- FMO4,PSMA4和VEGFA是关键基因,涉及骨质疏松症的发生.
- 这些基因与关键的信号通路和与骨代谢相关的免疫细胞相互作用有关.
- 这项研究为开发针对这些基因和相关途径的新型骨质疏松症治疗方法提供了基础.
相关概念视频
Hormones and Bone Tissue
2.9K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.9K
Bone Disorders
3.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.9K
Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
Bone Remodeling
38.5K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.5K
Role of Vitamins in Maintaining Bone Health
3.7K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.7K
Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K


